Challenges in Treating Statin-Associated Necrotizing Myopathy
Myalgia and mild elevation in muscle enzymes are common side effects of statin therapy. While these symptoms are generally self-limited, in rare cases, statin use is associated with an immune-mediated necrotizing myopathy caused by development of autoantibodies against HMG-CoA reductase. The primary...
Saved in:
Main Authors: | Patrick Webster, Nicholas Wiemer, Abdalhamid Al Harash, Cody Marshall, Nazia Khatoon, Michael Lucke |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2021/8810754 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
When Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy
by: Elena Obreja, et al.
Published: (2018-01-01) -
Immune-Mediated Necrotizing Myopathy Manifesting after Five Years of Statin Therapy
by: Nathan G. DeRon, et al.
Published: (2023-01-01) -
Statin-Associated Necrotizing Autoimmune Myositis Complicated by an Uncommon Adverse Effect to Treatment
by: Brian M. Fung, et al.
Published: (2019-01-01) -
When herpes zoster is not herpes: A case of statin-induced myopathy complicated by drug allergies
by: Hira Khalid Kareem, et al.
Published: (2025-01-01) -
Complete Recovery from COVID-19 Bilateral Pneumonia in an Immunosuppressed Man with Immune-Mediated Necrotizing Myopathy
by: Thomas C. Bolig, et al.
Published: (2020-01-01)